Minerva Neurosciences
NERV
NERV
85 hedge funds and large institutions have $163M invested in Minerva Neurosciences in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 26
31% less capital invested
Capital invested by funds: $236M → $163M (-$73M)
64% less call options, than puts
Call options by funds: $66K | Put options by funds: $181K
Holders
85
Holding in Top 10
1
Calls
$66K
Puts
$181K
Top Buyers
| 1 | +$1.13M | |
| 2 | +$1.1M | |
| 3 | +$747K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$619K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$464K |
Top Sellers
| 1 | -$4.82M | |
| 2 | -$3.14M | |
| 3 | -$777K | |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$776K |
| 5 |
Millennium Management
New York
|
-$752K |